FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Semaglutide Injection
Status: Currently in Shortage
»Date first posted: 03/31/2022
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Novo Nordisk, Inc. (Reverified 04/01/2024)

Company Contact Information:
833-493-4689

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Wegovy, Injection, .25 mg/.5 mL (NDC 0169-4525-14)	Limited Availability	Estimated shortage duration TBD	Demand increase for the drug
Wegovy, Injection, .5 mg/.5 mL (NDC 0169-4505-14)	Limited Availability	Estimated shortage duration TBD	Demand increase for the drug
Wegovy, Injection, 1 mg/.5 mL (NDC 0169-4501-14)	Limited Availability	Estimated shortage duration TBD	Demand increase for the drug
Wegovy, Injection, 1.7 mg/.75 mL (NDC 0169-4517-14)	Limited Availability	Estimated shortage duration TBD	Demand increase for the drug
Wegovy, Injection, 2.4 mg/.75 mL (NDC 0169-4524-14)	Available
Ozempic, Injection, 1.34 mg/1 mL (NDC 0169-4130-13)	Available
Ozempic, Injection, 2.68 mg/1 mL (NDC 0169-4772-12)	Available
Ozempic, Injection, .68 mg/1 mL (NDC 0169-4181-13)	Available